1. Market Research
  2. > Pharmaceutical Market Trends
Infertility Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

Infertility Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • October 2020
  • 117 pages
  • ID: 5986872
  • Format: PDF
  • Mordor Intelligence LLP


Table of Contents

Search Inside

The infertility drugs market studied was anticipated to register a CAGR of 6.1% during the forecast period. The major factors attributing to the growth of the market are significant changes in lifestyle which contributed to a rise in the number of (PCOS) Polycystic ovary syndrome cases, urinary, and breast cancers. The rise in the prevalence of cancers resulting in increased exposure to radiation which leads to infertility. As per the U.S. Department of Health and Human Services (HHS) report, in 2019, PCOS is a major health problem that affects 1 in 10 women of childbearing age across the globe. Thus, rising gynecological disorders resulting in decreased fertility rate is likely to fuel the global infertility drugs market.

Key Market Trends
Female Infertility Drugs Segment is Expected to Hold the Major Market Share in the Infertility Drugs Market

The female infertility drugs segment is expected to dominate the industry over the forecast period. The lucrative growth of the segment can be attributed to the higher incidences of infertility and misconception (as women are compared to men). The major cause of infertility among women is an increased prevalence of thyroid and breast cancer that necessitate higher exposure to radiation leading to a steep decrease in fertility rate. For instance, according to the factsheet published by the National Institutes of Health, the fertility rate of women decreases by half in their thirties. The report states that women’s chance of conception declines significantly after age 35.6, whereas male fertility declines gradually and among the women with any type of cancer. The increase in the consumption of smoking and alcohol and the increasing incidence of various disorders, like PCOS and uterine fibroids, result in higher demand. This factor is expected to fuel the growth of the segment.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the global infertility drugs market during the forecast period. This dominance is mainly owing to rising incidences of menopausal disorders, urinary infections, thyroid problems, endometriosis, and others due to busy lifestyles and a rise in stress among women. As per the Centers for Disease Control and Prevention CDC report published in 2019, PCOS affects around 6% to 12% representing more than 5 million women of reproductive age. Also, a steep rise in oligozoospermia, varicocele, diabetes, and others among men in the United States propels the revenue share in the region. Additionally, the presence of more number of reproductive endocrinologists along with advanced healthcare infrastructure fuels the market growth in the United States. Government expenditure for the women healthcare awareness with growing geriatric women population and early product launches are expected to further contribute its outstanding share in the global market.

Competitive Landscape
The global infertility drugs market is moderately competitive and consists of several major players. Some prominent players in the market are implementing various strategies such as launching new products and making acquisitions to consolidate their market positions across the globe. Furthermore, a steep rise in the availability of public fundings to develop these drugs is also expected to fuel the market. In December 2019, Allergan announced that its product PrFIBRISTAL was publicly funded through the Ontario Drug Benefit (ODB) Formulary and the Non-Insured Health Benefits (NIHB) Program. PrFIBRISTAL is used in first-in-class medical treatment for uterine fibroids, which lead to infertility. The uterine fibroids are the most common gynecological tumors which affect almost one-in-three Canadian women of reproductive age. Such encouraging public funds, innovative approaches to treat infertility are likely to positively impact the market during the forecast period. Some of the companies which are currently dominating the market are Ferring Pharmaceuticals Inc., Merck KGaA, Bayer AG, Pfizer Inc., and Novartis AG

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Autoinjectors Market by Therapy, Type, Route of administration, End User - Global Forecast to 2025

  • $ 4950
  • December 2020
  • 177 pages

The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence ...

  • World
  • United States
  • Chronic Disease
  • Pharmaceutical
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Pharmaceuticals Markets in China $ 4000 January 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on